Frederic Mack
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Genetics 18
- Glioma Diagnosis and Treatment 18
-
- Brain Metastases and Treatment 5
- Co-authors
- Martin Glas (12 shared papers)Ulrich Herrlinger (12 shared papers)Björn Scheffler (7 shared papers)Niklas Schäfer (10 shared papers)Elke Hattingen (1 shared paper)Brigitta G. Baumert (1 shared paper)Nico Schäfer (1 shared paper)Moritz Stuplich (8 shared papers)
- Journals
- Oncology (3 papers)Neuro-Oncology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Journal of Clinical Oncology (2 papers)Journal of Neuro-Oncology (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Frederic Mack
19 papers receiving 1.1k citations
Frederic Mack's Hit Papers
Peers
Comparison fields: 5 of 64
- Genetics 721
- Cancer Research 161
- Pulmonary and Respiratory Medicine 277
- Oncology 155
- Radiology, Nuclear Medicine and Imaging 131
Countries citing papers authored by Frederic Mack
This map shows the geographic impact of Frederic Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Mack more than expected).
Fields of papers citing papers by Frederic Mack
This network shows the impact of papers produced by Frederic Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Mack. The network helps show where Frederic Mack may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederic Mack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 431 |
| 2 | 2016 | 157 | |
| 3 | 2015 | 124 | |
| 4 | 2015 | 106 | |
| 5 | 2012 | 49 | |
| 6 | 2019 | 39 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 23 | |
| 9 | 2013 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2011 | 16 | |
| 12 | 2014 | 15 | |
| 13 | 2016 | 14 | |
| 14 | 2016 | 13 | |
| 15 | 2017 | 13 | |
| 16 | 2018 | 13 | |
| 17 | 2012 | 9 | |
| 18 | 2014 | 6 | |
| 19 | 2019 | 1 |
About Frederic Mack
Frederic Mack is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Ophthalmology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (5 papers), Nanoplatforms for cancer theranostics (1 paper), Multiple Sclerosis Research Studies (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Genetics (721 citations), Cancer Research (161 citations), Pulmonary and Respiratory Medicine (277 citations), Oncology (155 citations) and Radiology, Nuclear Medicine and Imaging (131 citations). Frederic Mack has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Martin Glas, Ulrich Herrlinger, Björn Scheffler, Niklas Schäfer, Elke Hattingen, Brigitta G. Baumert, Nico Schäfer, Moritz Stuplich, Sied Kebir and Matthias Simon. Their work appears in journals such as Oncology, Neuro-Oncology, Journal of Cancer Research and Clinical Oncology, Journal of Clinical Oncology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.